| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |